This course has expired. View available courses.
Infectious Disease
Meningococcal Type B – A pharmacist’s guide to protecting patients against the most prevalent form of invasive meningococcal disease (IMD) in Canada
Pharmacists play a key role in ensuring patients are educated about vaccines and are getting vaccinated against an increasing number of vaccine preventable diseases. Pharmacists have demonstrated that they can increase access and immunization rates against serious infections such as influenza. With the proper skillset, they can extend this success to other important immunizations for their patients.
This program will provide pharmacists with key information on meningococcal type B immunization. This infection is the most prevalent form of invasive meningococcal disease (IMD) in Canada. Although this infection is relatively rare, no other bacterial agent may kill as swiftly after bloodstream invasion as the meningococcus. It is crucial for pharmacists to be able to discuss the disease, its complications, the vaccine options, as well as, knowhow to integrate it into pharmacy practice.
DURATION
1 Hour
PROFESSION
Pharmacy
# OF CREDITS
1.25
ACCREDITATION
CCCEP
EXPIRY DATE
2021-07-15
Pharmacists play a key role in ensuring patients are educated about vaccines and are getting vaccinated against an increasing number of vaccine preventable diseases. Pharmacists have demonstrated that they can increase access and immunization rates against serious infections such as influenza. With the proper skillset, they can extend this success to other important immunizations for their patients.
This program will provide pharmacists with key information on meningococcal type B immunization. This infection is the most prevalent form of invasive meningococcal disease (IMD) in Canada. Although this infection is relatively rare, no other bacterial agent may kill as swiftly after bloodstream invasion as the meningococcus. It is crucial for pharmacists to be able to discuss the disease, its complications, the vaccine options, as well as, knowhow to integrate it into pharmacy practice.
Faculty
Mark Awuku, MB, ChB, FRCP(C), FAAP, FGCP, LLD (Honoris Causa)
Nancy Waite, BScPhm, PharmD
Ajit Johal, BScPhm, ISTM
Learning objectives
Upon successful completion of this continuing education program, the pharmacist will be better able to:
- Describe meningococcal disease burden, epidemiology, disease significance & severity
- Review the challenges to MenB vaccine development, the indications and modes of action
- Highlight the growing body of scientific evidence supporting MenB vaccination e.g. real-world experience, dosing schedules, persistence data, immunogenicity data spanning the age cohorts at risk of disease
- Practical integration of non-publicly funded vaccines in the pharmacy: how to discuss MenB vaccination, targeting patients not seen as often by other healthcare professionals, practical vaccine administration considerations and how to address questions/concerns from parents/patients